Jaypirca has been approved in the US since 2023 as a third-line treatment for CLL/SLL patients, after earlier treatment with ...

Marcus Evans will host the PharmaMarketing Summit from 21 to 22 January 2027 at the prestigious Four Seasons Hotel Westlake ...

The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to three scientists – Karl Deisseroth, Peter Hegemann ...

Isao Teshirogi, Shionogi's chief executive. Shionogi has reached a $2 billion agreement to buy Anglo-US biotech IntraBio and ...

If it reaches the market, profits on lixudebart sales will be shared 55% to CSL and 45% to Alentis. Under the terms of the ...

Bayer has joined the ranks of pharma multinationals planning major new facility investments in the US, revealing a plan to ...

The personalized cancer vaccine field has reached a defining milestone. With Moderna and Merck reporting positive initial ...

Frontiers Health 2026, strengthening a long-standing collaboration dedicated to advancing conversations around innovation in ...

AbbVie's long-acting anti-IL-13 antibody zumilokibart – the main asset in its $10.9 billion takeover of Apogee Therapeutics – ...

In the largest venture financing round this week, Varda Space Industries closed a $251 million financing round to help fund ...

Sanofi's long-running R&D alliance with Regeneron has gone up a gear with a partnership – worth up to $8 billion – that spans ...

Bayer has looked internally for a new chief medical officer, appointing Dr Christoph Koenen to the position in addition to ...